<DOC>
	<DOCNO>NCT02051387</DOCNO>
	<brief_summary>Despite recent advance understand treatment schizophrenia , devastate disease still affect one percent world 's population . Existing antipsychotic reduce psychotic symptom generally effective treating call negative symptom blunt affect social withdrawal cognitive disturbance due disease . Furthermore , significant portion patient refractory current treatment . Therefore new treatment strategy need . Several study suggest strong association schizophrenia endocannabinoid system . This system mediate e.g . pro-psychotic effect best-known ingredient cannabis plant - delta-tetrahydrocannabinol ( Δ9-THC ) . While pro-psychotic Δ9-THC know abet onset schizophrenia , another , non-psychotomimetic plant ingredient - cannabidiol - recently show exert antipsychotic effect similar one effective modern antipsychotic , amisulpride , induce significantly less side effect . In phase I safety study , investigator evaluate pharmacokinetics , pharmacoequivalence , drug-drug interaction profile current antipsychotic new tablet pharmaceutical preparation cannabidiol healthy volunteer .</brief_summary>
	<brief_title>Cannabidiol Different Type Antipsychotic : Drug Delivery Interaction Study</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<mesh_term>Sultopride</mesh_term>
	<mesh_term>Sulpiride</mesh_term>
	<criteria>Informed consent give subject Both , female male subject may participate Age 18 45 Negative drug screening time screen Nonsmoking In female participant fertile age , reliable contraception , mean contraception 's pearlindex equal small 1 . Body Mass Index 18 30 Lack accountability Any current psychiatric disorder Structured Clinical Interview DSMIV ( SCID ) time screen Pregnancy lactation phase female time screen Any known psychiatric neurological illness participant 's history . Known family history concern psychiatric disorder Relevant use cannabis ( define present state knowledge five time lifetimeconsumption consumption least one year ) Severe physical ( internal ) neurological illness , especially cardiovascular , renal , advanced respiratory , haematological endocrinological failure infectious disease ( acute hepatitis A , B C HIV ) assess time screen subject 's history , clinical examination laboratory testing , discretion investigator Consumption illicit drug ( except cannabis history , see )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>